Market Cap (In KRW)
22.26 Billion
Revenue (In KRW)
-
Net Income (In KRW)
-53.4 Billion
Avg. Volume
1.2 Million
- Currency
- KRW
- Country
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 999.0-2130.0
- PE
- -
- EPS
- -
- Beta Value
- 0.769
- ISIN
- KR8840140006
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Industry
- CEO
- Dr. Luke Yun Suk Oh Ph.D.
- Employee Count
- -
- Website
- https://www.neoimmunetech.com
- Ipo Date
- 2021-03-16
- Details
- NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland.
More Stocks
-
NIM
-
ELECTCASTElectrosteel Castings Limited
ELECTCAST
-
RBLBANKRBL Bank Limited
RBLBANK
-
SLMNSolis Minerals Ltd.
SLMN
-
MAA
-
MAITHANALLMaithan Alloys Limited
MAITHANALL
-
5071
-
SABEVENTS